Fertility Health Test

A 45-plus biomarker fertility assessment combining a full hormonal panel with AMH (ovarian reserve), thyroid function, diabetes screening, full blood count, heart health, iron status, and nutritional markers. Designed to provide a comprehensive picture of reproductive readiness alongside general health.

Fertility is influenced by far more than reproductive hormones alone. Thyroid dysfunction, iron deficiency, blood sugar dysregulation, and vitamin deficiencies can all impair conception and early pregnancy outcomes, yet they are frequently overlooked in standard fertility investigations. This panel takes a whole-body approach, combining the core reproductive markers with the metabolic and nutritional parameters that support a healthy conception. Anti-Mullerian hormone (AMH) provides an estimate of ovarian reserve — the remaining pool of eggs — which is useful both for women actively trying to conceive and those considering the timing of future family planning. AMH does not predict the ability to conceive but offers context about the biological window that informs decision-making. The hormonal panel covers the full pituitary-ovarian axis alongside thyroid markers that are critical for early pregnancy viability. The broader health markers — full blood count, heart health, diabetes screening, iron stores, and nutritional parameters — ensure that any underlying conditions that could affect fertility or pregnancy health are identified early. Fasting for 8 to 12 hours is required, blood should be drawn on days 2 to 5 of the menstrual cycle, and hormonal contraception should be discontinued for accurate results. At 190 pounds for 45-plus biomarkers, this panel offers substantial depth at a competitive price point for fertility-focused screening.